Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

Similar articles for PubMed (Select 23189187)

1.

Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora S, Hirata H, Ueno K, Singh K, Tanaka Y, Dahiya R.

PLoS One. 2012;7(11):e50203. doi: 10.1371/journal.pone.0050203. Epub 2012 Nov 26.

2.

miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Chen X, Ruan A, Wang X, Han W, Wang R, Lou N, Ruan H, Qiu B, Yang H, Zhang X.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1295-304. doi: 10.1007/s00432-014-1690-7. Epub 2014 May 7.

PMID:
24802708
3.

microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.

Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, Block K, Kasinath BS, Abboud HE, Choudhury GG.

PLoS One. 2012;7(6):e37366. doi: 10.1371/journal.pone.0037366. Epub 2012 Jun 4.

4.

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.

5.

MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.

Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B, Ding T, Cao Y, Tian Z, Shi Q, He X.

BMC Cancer. 2012 Nov 23;12:546. doi: 10.1186/1471-2407-12-546.

6.

MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.

J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.

PMID:
23454155
7.

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O.

Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13.

PMID:
23150176
8.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.

9.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R.

PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.

10.

Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.

Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo X, Qin J, Chen J, Lu R.

Biochem Biophys Res Commun. 2012 Mar 23;419(4):621-6. doi: 10.1016/j.bbrc.2012.02.060. Epub 2012 Feb 17.

PMID:
22369946
11.

Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.

Hirata H, Ueno K, Nakajima K, Tabatabai ZL, Hinoda Y, Ishii N, Dahiya R.

Br J Cancer. 2013 May 28;108(10):2070-8. doi: 10.1038/bjc.2013.173. Epub 2013 Apr 16.

12.

miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.

Lu R, Ji Z, Li X, Zhai Q, Zhao C, Jiang Z, Zhang S, Nie L, Yu Z.

J Cancer Res Clin Oncol. 2014 Mar;140(3):387-97. doi: 10.1007/s00432-013-1577-z. Epub 2014 Jan 3.

PMID:
24384875
13.

miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.

Chen X, Pan M, Han L, Lu H, Hao X, Dong Q.

FEBS Lett. 2013 Nov 15;587(22):3729-37. doi: 10.1016/j.febslet.2013.09.044. Epub 2013 Oct 15.

14.

Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.

Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.

Int J Oncol. 2012 Sep;41(3):805-17. doi: 10.3892/ijo.2012.1543. Epub 2012 Jul 3.

15.

MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.

Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, Tanaka Y, Dahiya R, Yamamura S.

PLoS One. 2013 Jul 2;8(7):e67686. doi: 10.1371/journal.pone.0067686. Print 2013.

16.

Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.

Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M, Enokida H.

Cancer Sci. 2013 Nov;104(11):1411-9. doi: 10.1111/cas.12240. Epub 2013 Aug 22.

PMID:
23889809
17.

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

Liu ZL, Wang H, Liu J, Wang ZX.

Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.

PMID:
22956424
18.

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN.

Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z, Chun-Sheng K.

BMC Cancer. 2010 Jul 12;10:367. doi: 10.1186/1471-2407-10-367.

19.

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.

White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM.

Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27.

20.

The VHL-dependent regulation of microRNAs in renal cancer.

Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM.

BMC Med. 2010 Oct 21;8:64. doi: 10.1186/1741-7015-8-64.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk